Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

A New Method for the Cytofluorometric Analysis of Mitochondrial Membrane Potential Using the J-Aggregate Forming Lipophilic Cation 5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine Iodide (JC-1)

Andrea Cossarizza, M. Baccarani-Contri, Galina Kalashnikova et al. · Biochemical and Biophysical Research Communications · 1993 · 1K citations · Full text

Life Sciences, Biophysics, Cell Biology +10

Ruthenium metallopharmaceuticals

Michael J. Clarke · Coordination Chemistry Reviews · 2003 · 675 citations

Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Maryla Krajewska, Steven F. Moss, Stanisław Krajewski et al. · PubMed · 1996 · 327 citations

Medicine, Oncology, Pathology +17

Resistance of colon cancer cells to long‐term 5‐fluorouracil exposure is correlated to the relative level of Bcl‐2 and Bcl‐X_L in addition to <i>Bax</i> and <i>p53</i> status

Sabine Violette, Laurent Poulain, Elisabeth Dussaulx et al. · International Journal of Cancer · 2002 · 212 citations

Medicine, Oncology, Pharmacology +17

The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.

Felix Kratz, M. Hartmann, Bernhard K. Keppler et al. · Journal of Biological Chemistry · 1994 · 202 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12